JPRN-UMIN000019305已完成4 期
Dynamics of iron status in chronic hemodialysis patients -measurement of iron loss and periodic supplementation- - Dynamics of iron status in chronic hemodialysis patients
Deaprtment of nephrology, Kyoto University Hospital0 个研究点目标入组 250 人开始时间: 2015年10月9日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 250
研究概览
简要总结
Annual iron loss by hemodialysis is around 500mg in Japan. (Am J Nephrol. 2016;43(1):32-8)
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) active malignancy, hematological disorder, iron looser by gastro-intestinal bleeding, etc. 2) allergy against ESA 3) pregnant or considering pregnanct woman, lactating woman 4) patients attending other clinical trials 5) improper patien
研究者
相似试验
已完成
4 期
Comparison Study of Two Iron Compounds for Treatment of Anemia in Hemodialysis PatientsAnemia of Chronic Kidney DiseaseNCT02198495Medical University of Vienna143
已完成
不适用
Evaluation of iron status in hemodialysis patients under maintenance therapy with intravenous iroEnd stage kidney disease on dialysisUrological and Genital DiseasesChronic kidney disease, stage 5ISRCTN12825165Dr. med. A. Kistler39
终止
4 期
A Clinical Trial of Oral Versus IV Iron in Patients With Chronic Kidney DiseaseIron-deficiency AnemiaChronic Kidney DiseaseNCT00830037Indiana University136
已完成
不适用
Effect of Parenteral Iron Therapy on Inflammatory Response and Oxidative Stress Chronic HemodialysisHemodialysisInflammationChronic Kidney DiseaseNCT00583973University of California, Davis11
已完成
3 期
Maintenance intravenous iron in hemodialysis patients to minimize erythropoietin doses: A double-blinded, randomized controlled trialMaintenance hemodialysis patients with no iron deficiency anemiaHemodialysisIntravenous iron sucroseErythropoietin-stimulating agentIron deficiency anemiaTCTR20190707001The Kidney Foundation of Thailand72